The United States Food and Drug Administration (FDA) will announce in the coming days that the Johnson & Johnson vaccine is linked to a serious side effect called Guillain-Barr\u00e9 syndrome.<\/p>\n
The Washington Post broke the news<\/a>.<\/p>\n Out of the 12.8 million people who have received the Johnson & Johnson shot, there were fewer than 100 cases of the syndrome, the report said<\/a>.<\/p>\n The FDA will insist the benefits of the vaccine far outweigh any risks.<\/p>\n The FDA plans to say this week that the Johnson & Johnson vaccine has been linked to a serious but rare side effect called Guillain-Barr\u00e9 syndrome, according to four people who spoke on the condition of anonymity to describe internal discussions. https:\/\/t.co\/5p5IyPRCp4<\/a><\/p>\n — The Washington Post (@washingtonpost) July 12, 2021<\/a><\/p><\/blockquote>\n\n